Lists of action films

WARNER BROS. DISCOVERY, INC. (NASDAQ: WBD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Warner Bros. Discovery, Inc. (NASDAQ: WBD)

Retrieved on: 
Tuesday, October 11, 2022
Securities Act of 1933, SEC, Advertising, Mergers and acquisitions, NASDAQ, Discovery, Inc., HBO, Complaint, Register, HBO Max, Labour government, AT, Court, Investment, Company, AT&T, NEW, Discovery, District court, Form, Prospectus, WBD, GLOBE, Lists of action films, The Legal 500, Security (finance), Online gambling, WarnerMedia

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who: (1) exchanged Discovery, Inc. (“Discovery”) common stock for Warner Bros. Discovery, Inc. (“WBD”) (NASDAQ: WBD) common stock pursuant or traceable to Discovery’s February 4, 2022 Registration Statement on Form S-4 (the “Registration Statement”) and Joint Proxy Statement/Prospectus filed with the SEC on February 10, 2022 (the “Prospectus”), or (2) purchased shares of WBD common stock on the open market traceable to the Prospectus through the date of the filing of the complaint. The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Act of 1933.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • If you wish to serve as lead plaintiff, you must move the Court no later than November 22, 2022.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (NASDAQ: FLGT)

Retrieved on: 
Tuesday, October 11, 2022
Physician, Genetics, Remuneration, News, Office of Inspector General, U.S. Department of Health and Human Services, Anti-Kickback Statute, SEC, Reward, Advertising, NASDAQ, Patient, Labour government, Court, Investment, Company, NEW, Justice, U.S. Department of Justice Office of Legislative Affairs, Battle of Saint-Fulgent, Medicare, District court, Stark, Lists of schools in England, Securities Exchange Act of 1934, Genetic testing, GLOBE, Central District, Lists of action films, The Legal 500, Disclosure, COVID-19, Stark Law, Health, Tobacco, Pharmaceutical industry, Online gambling, Security (finance)

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • If you purchased Fulgent securities, and/or would like to discuss your legal rights and options please visit Fulgent Genetics, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SEMA4 HOLDINGS CORP. (NASDAQ: SMFR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Sema4 Corp. (NASDAQ: SMFR)

Retrieved on: 
Tuesday, October 11, 2022
News, Risk, Oncology, Advertising, Genomics, District, NASDAQ, Patient, Labour government, Research, SMFR, Workforce, Court, Investment, Company, Artificial intelligence, NEW, District court, Lists of schools in England, Securities Exchange Act of 1934, GLOBE, Lists of action films, The Legal 500, Security (finance), Pharmaceutical industry, Tobacco

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Sema4 Holdings Corp. (“Sema4” or the “Company”) (NASDAQ: SMFR) between March 14, 2022 and August 15, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the District of Connecticut and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the District of Connecticut and alleges violations of the Securities Exchange Act of 1934.
  • If you purchased or acquired Sema4 securities, and/or would like to discuss your legal rights and options please visit Sema4 Holdings Corp.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

TUSIMPLE HOLDINGS INC. (NASDAQ: TSP) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against TuSimple Holdings Inc. (NASDAQ: TSP)

Retrieved on: 
Tuesday, October 11, 2022
News, TSP, Securities Act of 1933, The Wall Street Journal, Advertising, Level 4, NASDAQ, IPO, Register, Labour government, Court, Investment, Company, Technology, NEW, Accident, District court, Ecosystem, Securities Exchange Act of 1934, Safety, GLOBE, Lists of action films, The Legal 500, AFN, Security (finance), Risk management, Prospectus

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired the common stock of TuSimple Holdings Inc. (“TuSimple” or the “Company”) (NASDAQ: TSP) pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Registration Statement”) issued in connection with TuSimple’s April 15, 2021 initial public offering (“IPO”); and/or purchased or otherwise acquired TuSimple securities between April 15, 2021 and August 1, 2022, both dates inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of California and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • TuSimple develops autonomous technology specifically designed for semi-trucks in the United States and internationally.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

STITCH FIX, INC. (NASDAQ: SFIX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Stitch Fix, Inc. (NASDAQ: SFIX)

Retrieved on: 
Tuesday, October 11, 2022
News, Advertising, NASDAQ, Labour government, Program, Court, Investment, Company, NEW, Fix, District court, Shoe, Lists of schools in England, Securities Exchange Act of 1934, GLOBE, Lists of action films, The Legal 500, Security (finance), Shoemaking, Sewing, Freestyle, Stitch Fix, Stitch

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Stitch Fix, Inc. (“Stitch Fix” or the “Company”) (NASDAQ: SFIX) between December 8, 2020, and March 8, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Stitch Fix sells a range of apparel, shoes, and accessories through its website and mobile application.
  • Traditionally, Stitch Fix sold products as a Fix box, through which the customer would receive a monthly box of items chosen by a personal stylist.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

HUMANIGEN, INC. (NASDAQ: HGEN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Humanigen, Inc. (NASDAQ: HGEN)

Retrieved on: 
Tuesday, October 11, 2022
News, Advertising, Cytokine, District, NASDAQ, Regulation of tobacco by the U.S. Food and Drug Administration, Patient, Labour government, Court, Investment, Company, Partnership, EUA, NEW, Food, Emergency Use Authorization, Immune system, Defendant, District court, National, Lists of schools in England, Securities Exchange Act of 1934, Letter, GLOBE, Lists of action films, Death, The Legal 500, FDA, COVID-19, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Humanigen, Inc. (“Humanigen” or the “Company”) (NASDAQ: HGEN) between May 28, 2021 and July 12, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the District of New Jersey and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the District of New Jersey and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Opendoor Class Action Complaint Filed: Johnson Fistel Encourages Shareholders to Contact the Firm

Retrieved on: 
Saturday, October 8, 2022
SAN, Risk, Class, Mergers and acquisitions, Lists of action films, NASDAQ, Court, Company, Learning, Defendant, Lists of schools in England, GLOBE, LLP, Security (finance), Opendoor, Algorithm

SAN DIEGO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Opendoor Technologies Inc. (Opendoor or the Company) (NASDAQ: OPEN).

Key Points: 
  • SAN DIEGO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Opendoor Technologies Inc. (Opendoor or the Company) (NASDAQ: OPEN).
  • Investors are hereby notified that they have until December 6, 2022 to move the Court to serve as lead plaintiff in this action.
  • An investor's ability to share any potential future recovery of the Opendoor class action lawsuit is not dependent upon serving as lead plaintiff.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

Pomerantz Law Firm Announces the Filing of a Class Action Against Opendoor Technologies Inc. and Certain Officers and Directors – OPEN

Retrieved on: 
Friday, October 7, 2022
SCH, Pomerantz, U.S. Securities and Exchange Commission, Securities Act of 1933, Risk, SEC, Registration statement, Class, Review, Tripura Merger Agreement, Person, District, NASDAQ, Complaint, Register, Court, Company, Technology, Defendant, Acquisition, Industry, District court, Initial, Form, Securities Exchange Act of 1934, Lists of schools in England, GLOBE, Ext, Bloomberg, Lists of action films, Security (finance), Opendoor, Mergers and acquisitions, Algorithm

NEW YORK, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Opendoor Technologies Inc. (Opendoor or the Company) (NASDAQ: OPEN) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Opendoor Technologies Inc. (Opendoor or the Company) (NASDAQ: OPEN) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Latch Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their LTCH Losses

Retrieved on: 
Friday, October 7, 2022
SAN, Mission statement, Lists of action films, LTCH, NASDAQ, Court, Company, Learning, Defendant, Lists of schools in England, GLOBE, LLP, Security (finance), Tobacco, Latch

The class action is on behalf of shareholders who purchased or otherwise acquired Latch securities between May 13, 2021 and August 25, 2022.

Key Points: 
  • The class action is on behalf of shareholders who purchased or otherwise acquired Latch securities between May 13, 2021 and August 25, 2022.
  • Investors are hereby notified that they have until October 31, 2022 to move the Court to serve as lead plaintiff in this action.
  • An investor's ability to share any potential future recovery of the Latch class action lawsuit is not dependent upon serving as lead plaintiff.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Centessa Pharmaceuticals plc of Class Action Lawsuit and Upcoming Deadline – CNTA

Retrieved on: 
Thursday, October 6, 2022
News, Pomerantz, U.S. Securities and Exchange Commission, Securities Act of 1933, Observation, SEC, Registration statement, Class, CNTA, ADS, Autosome, Person, NASDAQ, Complaint, IPO, Patient, Â, Register, Court, Company, BID, American depositary receipt, Polycystic kidney disease, Defendant, District court, Form, Securities Exchange Act of 1934, Liver, Lists of schools in England, A1AT, GLOBE, Central District, Ext, Prospectus, DNA, AE, LLP, Lists of action films, AATD, Security (finance), Pharmaceutical industry, Animal

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (Centessa or the Company) (NASDAQ: CNTA) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (Centessa or the Company) (NASDAQ: CNTA) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.